Exponent EXPO
Exponent is an engineering and science consulting firm that solves technical problems for regulated industries. Exponent combines a very solid balance sheet (Net Debt/EBITDA 0.10) with exceptional profitability (ROE 31.20%, ROIC 28.90%) and double-digit growth (revenue +12%), although its demanding valuation (P/E 28.78) limits upside.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Exponent is an engineering and science consulting firm that solves technical problems for regulated industries. Exponent combines a very solid balance sheet (Net Debt/EBITDA 0.10) with exceptional profitability (ROE 31.20%, ROIC 28.90%) and double-digit growth (revenue +12%), although its demanding valuation (P/E 28.78) limits upside.
Score by category
| Category | Score |
|---|---|
| Financial health | 8.1 |
| Quality / Moat | 7.7 |
| Valuation | 3.9 |
| Growth | 7.0 |
| Dividend | 6.5 |
| Momentum | 4.4 |
| Risk & Context | 7.8 |
OVERALL SCORE: 6.5/10
Context and risks
Exponent is an engineering and science consultancy with low debt (Net Debt/EBITDA 0.10) and no direct exposure to commodities, interest rates, or shipping routes. The macro context does not materially affect its business.
News considered in the analysis
- Exponent (EXPO) Could Be 17% Undervalued On Strong Results And Higher Guidance — Resultados sólidos y guía al alza; la noticia refuerza la confianza en el crecimiento, aunque parte del optimismo ya está en el precio.
- Exponent (EXPO) Q2 2026 Earnings Call Transcript — La llamada de resultados confirma la evolución positiva del negocio y la demanda de sus servicios de ingeniería.
- Wall Street Analysts Predict a 25.65% Upside in Exponent (EXPO): Here's What You Should Know — Proyección de analistas sobre potencial de revalorización; es una opinión con probabilidad incierta de materializarse.
- Are Business Services Stocks Lagging Exponent (EXPO) This Year? — Comparativa genérica de sectores sin información nueva sobre la empresa.
- Xeinadin appoints John Dwyer as new chairman — Noticia sobre otra empresa, sin relevancia para Exponent.
Verdict: Hold: quality and growth justify the premium, but the price already discounts much of the good outlook.
Main risk: The main risk is the demanding valuation (P/E 28.78, EV/EBITDA 22.24): any slowdown in demand for its consulting services could compress the multiple.
Other Industrials companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →